Stem cell treatment for diabetes has shown promise in preclinical trials and some early phase clinical trials. It has demonstrated potential in controlling blood sugar levels and reducing insulin dependency in some patients. However, larger clinical trials are necessary to determine the efficacy and safety of the treatment on a wider scale.